Sexual health
PT-141 Dosage: Start Low and Time It Right
A brain-acting libido peptide with real approval and a nausea cost.
The quick version
- A brain-acting libido peptide. FDA approved as Vyleesi.
- Improved desire in trials of 1247 women; nausea is the main cost.
- Approved dose 1.75 mg as needed; many start lower to test for nausea.
What it is
PT-141, or bremelanotide, works in the brain to raise sexual desire, not blood flow like ED pills. It is FDA approved as Vyleesi for low desire in premenopausal women. Men use it off label too.
What the research shows
Approval came from two trials in 1247 women with low sexual desire. At 1.75 mg, women reported improved desire and less distress versus placebo, with small but real effect sizes (FDA Vyleesi label, 2019). It acts on melanocortin receptors in the brain. Nausea was the most common complaint in the trials.
What it felt like
I have tried PT-141 a handful of times. The effect was real but came with a wave of nausea and a flushed feeling for an hour or so. It is not a casual, no-cost option, and the timing window matters more than people expect.
Dosing reality
The approved dose is 1.75 mg under the skin, used as needed, not daily, and no more than once in 24 hours or 8 times a month. People who self-dose often start lower to test for nausea. Less is usually plenty.
The one mistake to avoid
The mistake is stacking a big dose right before a date. Too much just brings nausea and kills the mood. A small test dose on a low-stakes day shows you how you react.
Bottom line
PT-141 is one of the few approved options here and it works in the brain, but nausea is the price. Start small and learn your timing.
Reminder: I am not a doctor and this is not medical advice. It is my own notes and reading of the research. Peptides sit in a legal grey area, research-grade is a real category, and it is on you to verify your own compliance. Talk to a qualified professional before you start anything, especially if you take other medication.